Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Clinical Therapeutics
|
September 19, 2018
Pharmacokinetics of Single-dose Ertugliflozin in Patients With Hepatic Impairment
Vaishali Sahasrabudhe, Steven G Terra, Anne Hickman, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
February 26, 2019
A PK/PD study comparing twice-daily to once-daily dosing regimens of ertugliflozin in healthy subjects
Vikas Kumar Dawra, Yali Liang, Haihong Shi, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
May 1, 2021
End-to-end application of model-informed drug development for ertugliflozin, a novel sodium-glucose cotransporter 2 inhibitor
Daryl J Fediuk, Gianluca Nucci, Vikas K Dawra, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 22, 2024
Toward precision medicine: End-to-end design and construction of integrated microneedle-based theranostic systems
Yiming Qin, Feiyun Cui, Yifei Lu, et al.
Journal of Clinical Pharmacology
|
April 4, 2021
Meta-Analysis of Noncompartmental Pharmacokinetic Parameters of Ertugliflozin to Evaluate Dose Proportionality and UGT1A9 Polymorphism Effect on Exposure
Jean-Claude Marshall, Yali Liang, Vaishali Sahasrabudhe, et al.
Clinical Pharmacology in Drug Development
|
June 18, 2019
Bioequivalence of Ertugliflozin/Metformin Fixed-Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components
Vikas Kumar Dawra, Yali Liang, Hua Wei, et al.
Clinical Pharmacology in Drug Development
|
May 23, 2018
Assessment of the Drug Interaction Potential of Ertugliflozin With Sitagliptin, Metformin, Glimepiride, or Simvastatin in Healthy Subjects
Vikas Kumar Dawra, David L Cutler, Susan Zhou, et al.
Clinical Pharmacology in Drug Development
|
November 15, 2018
Effect of Food on the Pharmacokinetics of Ertugliflozin and Its Fixed-Dose Combinations Ertugliflozin/Sitagliptin and Ertugliflozin/Metformin
Vaishali Sahasrabudhe, Daryl J Fediuk, Kyle Matschke, et al.
AIDS Patient Care and Stds
|
June 28, 2012
Meta-analysis of gender differences in efficacy outcomes for HIV-positive subjects in randomized controlled clinical trials of antiretroviral therapy (2000-2008)
Guoxing Greg Soon, Min Min, Kimberly A Struble, et al.
Clinical Pharmacology in Drug Development
|
June 21, 2019
Bioequivalence of Ertugliflozin/Sitagliptin Fixed-Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components
Daryl J Fediuk, Kyle Matschke, Yali Liang, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Clinical Therapeutics
|
September 19, 2018
Pharmacokinetics of Single-dose Ertugliflozin in Patients With Hepatic Impairment
Vaishali Sahasrabudhe, Steven G Terra, Anne Hickman, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
February 26, 2019
A PK/PD study comparing twice-daily to once-daily dosing regimens of ertugliflozin in healthy subjects
Vikas Kumar Dawra, Yali Liang, Haihong Shi, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
May 1, 2021
End-to-end application of model-informed drug development for ertugliflozin, a novel sodium-glucose cotransporter 2 inhibitor
Daryl J Fediuk, Gianluca Nucci, Vikas K Dawra, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 22, 2024
Toward precision medicine: End-to-end design and construction of integrated microneedle-based theranostic systems
Yiming Qin, Feiyun Cui, Yifei Lu, et al.
Journal of Clinical Pharmacology
|
April 4, 2021
Meta-Analysis of Noncompartmental Pharmacokinetic Parameters of Ertugliflozin to Evaluate Dose Proportionality and UGT1A9 Polymorphism Effect on Exposure
Jean-Claude Marshall, Yali Liang, Vaishali Sahasrabudhe, et al.
Clinical Pharmacology in Drug Development
|
June 18, 2019
Bioequivalence of Ertugliflozin/Metformin Fixed-Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components
Vikas Kumar Dawra, Yali Liang, Hua Wei, et al.
Clinical Pharmacology in Drug Development
|
May 23, 2018
Assessment of the Drug Interaction Potential of Ertugliflozin With Sitagliptin, Metformin, Glimepiride, or Simvastatin in Healthy Subjects
Vikas Kumar Dawra, David L Cutler, Susan Zhou, et al.
Clinical Pharmacology in Drug Development
|
November 15, 2018
Effect of Food on the Pharmacokinetics of Ertugliflozin and Its Fixed-Dose Combinations Ertugliflozin/Sitagliptin and Ertugliflozin/Metformin
Vaishali Sahasrabudhe, Daryl J Fediuk, Kyle Matschke, et al.
AIDS Patient Care and Stds
|
June 28, 2012
Meta-analysis of gender differences in efficacy outcomes for HIV-positive subjects in randomized controlled clinical trials of antiretroviral therapy (2000-2008)
Guoxing Greg Soon, Min Min, Kimberly A Struble, et al.
Clinical Pharmacology in Drug Development
|
June 21, 2019
Bioequivalence of Ertugliflozin/Sitagliptin Fixed-Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components
Daryl J Fediuk, Kyle Matschke, Yali Liang, et al.
Page
of 5